Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) NLRP1 Antibodies:
anti-Human NLRP1 Antibodies:
anti-Mouse (Murine) NLRP1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal NLRP1 Primary Antibody for ICC, IF - ABIN4890403
Fahy, Exline, Gavrilin, Bhatt, Besecker, Sarkar, Hollyfield, Duncan, Nagaraja, Knatz, Hall, Wewers: Inflammasome mRNA expression in human monocytes during early septic shock. in American journal of respiratory and critical care medicine 2008
Show all 5 Pubmed References
Human Monoclonal NLRP1 Primary Antibody for ICC, IF - ABIN4340089
Kummer, Broekhuizen, Everett, Agostini, Kuijk, Martinon, van Bruggen, Tschopp: Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2007
mRNA expression levels of NLRP1 and NLRC4 (show NLRC4 Antibodies) were not altered in chronic hepatitis B patients, suggesting that these genes are not responsible for the impaired immune responses against HBV observed in these patients.
NLRP1 senses cellular infection by distinct invasive pathogens.
NLRP1 promotes melanoma growth by enhancing inflammasome activation and suppressing apoptotic pathways.
Two new mutations in NLRP1 (c.3641C>G, p.Pro1214Arg and c.2176C>T; p.Arg726Trp) were found to cause a new autoinflammatory syndrome, NLRP1-associated autoinflammation with arthritis and dyskeratosis.
Th17 micro-milieu via IL-17A (show IL17A Antibodies) regulates NLRP1-dependent CASP5 (show CASP5 Antibodies) activity in psoriatic skin autoinflammation.
HO-1 (show HMOX1 Antibodies) inhibited expression of activating transcription factor 4 (ATF4 (show ATF4 Antibodies)), which is a transcription factor regulating NLRP1 expression
Simvastatin intake in peripheral arterial disease patients increases in vitro reactivity of NLRP1 inflammasome gene expression in endothelial cells.
these findings establish a group of non-fever inflammasome disorders, uncover an unexpected auto-inhibitory function for the pyrin (show MEFV Antibodies) domain, and provide the first genetic evidence linking NLRP1 to skin inflammatory syndromes and skin cancer predisposition.
The NLRP3 (show NLRP3 Antibodies) and NLRP1 inflammasomes are activated in Alzheimer's disease
NLRP1 inflammasome is activated by extracellular acidosis through ASIC1a (show ACCN2 Antibodies) signal pathway.
The findings indicate that NLRP1 inflammasome activation does not significantly contribute to acute neural injury in the murine model of moderate CCI injury.
the aim of this study was to evaluate the effects of chronic dexamethasone (DEX) treatment on nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 1 (show PYDC1 Antibodies) (NLRP-1) inflammasome in male mice.
NLRP1 is an innate immune sensor that functions in the context of metabolic stress to produce IL-18 (show IL18 Antibodies), preventing obesity and metabolic syndrome.
these data identify NLRP1 as an essential mediator of the host immune response during IBD and cancer.
Data show that eicosanoid 15-deoxy-Delta(12,14)-PGJ2 (15d-PGJ2) and related cyclopentenone PGs inhibit caspase-1 (show CASP1 Antibodies) activation by the NLR (show CXCR5 Antibodies) family leucine-rich repeat protein (show LRRC10 Antibodies) (NLRP)1 and NLRP3 (show NLRP3 Antibodies) inflammasomes.
The NOD-like receptor NLRP1a/Caspase-1 (show CASP1 Antibodies) pathway is the best candidate to mediate the parasite-induced cell death.
Caspase-8 (show CASP8 Antibodies) promotes NLRP1/NLRP3 (show NLRP3 Antibodies) inflammasome activation and IL-1beta (show IL1B Antibodies) production in acute glaucoma.
These findings reveal Toxoplasma gondii as a novel activator of the NLRP1 and NLRP3 (show NLRP3 Antibodies) inflammasomes in vivo and establish a role for these sensors in host resistance to toxoplasmosis.
Arsenicals, including arsenic trioxide and sodium arsenite, inhibited activation of the NLRP1, NLRP3 (show NLRP3 Antibodies), and NAIP5/NLRC4 (show NLRC4 Antibodies) inflammasomes.
the NLRP1 and NLRP3 (show NLRP3 Antibodies) inflammasomes have a major role in neuronal cell death and behavioral deficits in stroke.
This gene encodes a member of the Ced-4 family of apoptosis proteins. Ced-family members contain a caspase recruitment domain (CARD) and are known to be key mediators of programmed cell death. The encoded protein contains a distinct N-terminal pyrin-like motif, which is possibly involved in protein-protein interactions. This protein interacts strongly with caspase 2 and weakly with caspase 9. Overexpression of this gene was demonstrated to induce apoptosis in cells. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined.
NACHT, leucine rich repeat and PYD containing 1
, NLR family protein 1
, NLR family, pyrin domain containing 1
, resistant anthrax lethal toxin
, NACHT, LRR and PYD domains-containing protein 1
, NLR family pyrin domain containing 1
, NACHT, LRR and PYD containing protein 1
, NACHT, leucine rich repeat and PYD (pyrin domain) containing 1
, caspase recruitment domain protein 7
, caspase recruitment domain-containing protein 7
, death effector filament-forming Ced-4-like apoptosis protein
, nucleotide-binding domain and caspase recruitment domain
, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 1
, NACHT/LRR/pyrin domain-containing protein 1
, caspase recruitment domain protein